WEBINAR REPLAY: "Chest Tube Management in Cardiac Surgery" | ERAS Cardiac Society Webinar in collaboration with CTSNet

Key speakers Marc Gillinov, MD, Jurij M. Kalisnik, MD, and Lenard Conradi, MD discuss the clinical implications of retained blood, current strategies in chest tube management, and the benefits of posterior pericardiotomy.
Webinar moderated by Kevin Lobdell, MD, and Marc Gerdisch, MD.

News

Retained Blood Syndrome Role in Complicating LVAD Recovery Discussed at International Heart Transplant Conference

— ClearFlow Executives Comment on Possible Solutions to Retained Blood Syndrome for  Challenging Patient Population– Anaheim, CA – April 28, 2016—Cardiac surgery investigators presented data revealing the role retained blood plays in complications after left ventricular assist device (LVAD) implantation this week at the International Society for Heart & Lung Transplantation 2016 Annual Meeting in Washington, DC. All patients recovering from LVAD implantation require chest tubes to drain…

Read more

New Data Indicates Patients with Retained Blood are 75% More Likely to Suffer from Hospital Acquired Infections After Heart Surgery

— ClearFlow Executives Comment on Need for New Protocols — Anaheim, CA – April 13, 2016—Clinical data presented at the Society of Cardiovascular Anesthesiologists (SCA) 2016 Annual Meeting and Workshops in San Diego last week indicated that Hospital Acquired Infections (HAI) are 75% more likely to occur in patients with interventions for Retained Blood Syndrome (RBS) after heart surgery than in patients who do not have RBS. All…

Read more

Study Reveals Retained Blood as Common Culprit Leading to Acquired Infections After Heart Surgery

— ClearFlow Executive Comments on Possible Solutions to Hospital Acquired Infections — Anaheim, CA – April 6, 2016—Cardiac anesthesia investigators from Germany presented data revealing the role retained blood plays in hospital acquired infections after heart surgery this week at the Society of Cardiovascular Anesthesiologists (SCA) 2016 Annual Meeting and Workshops in San Diego, CA. Critical care specialists from Charité – Universitätsmedizin Berlin’s Department of Anesthesiology and Intensive…

Read more

PleuraFlow Relieves Life-Threatening Pericardial Tamponade by Active Clearance of Chest Tubes after Heart Surgery

Anaheim, CA – March 30, 2016—Cardiac Surgeons at the Montreal Heart Institute have published a report featured in this month’s Annals of Thoracic Surgery detailing how active clearance of chest tubes in the ICU non surgically treated a life-threatening episode of pericardial tamponade in a patient recovering from heart surgery (Annals of Thoracic Surgery, 101: 1159-1163, 2016). Affiliated with Université de Montréal in Quebec, the Montreal Heart Institute…

Read more

Getinge Group Receives Innovative Technology Designation from Novation for the ClearFlow PleuraFlow® Active Clearance Technology® (ACT™) System

Designation recognizes the development of new solutions that benefit the healthcare industry WAYNE, N.J., March 29, 2016 /PRNewswire/ — Getinge Group announced its Maquet V8 Catheter and Maquet PleuraFlow Active Clearance Technology System have received Innovative Technology designation from Novation, the leading healthcare services company that serves the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association, and Provista. The designation was based on…

Read more

Newly Published Study Confirms Reduction in Retained Blood and Postoperative Atrial Fibrillation After Heart Surgery with PleuraFlow Active Clearance Technology

Anaheim, CA – March 9, 2016—ClearFlow Inc., a medical device company based in Anaheim, California, has announced the publication of significantly positive results in a study evaluating the company’s PleuraFlow® Active Clearance Technology® System.  Data indicating a marked reduction in Retained Blood Syndrome (RBS) and Postoperative Atrial Fibrillation (POAF) among patients recovering from heart surgery was published in the March issue of the Journal of Thoracic and Cardiovascular…

Read more

ClearFlow’s PleuraFlow System Exhibited at EACTS Meeting

Amsterdam, Netherlands – October 8, 2015—ClearFlow Inc., a medical device company based in Anaheim, California, USA, exhibited its innovative PleuraFlow® Active Clearance Technology® System at the 29th annual Association for Cardio-Thoracic Surgery (EACTS) meeting in Amsterdam this week. The EACTS Annual Meeting is the largest cardio-thoracic meeting in the world, a position it has maintained for over a decade, and this year’s event featured ClearFlow’s PleuraFlow technology for…

Read more

Unmet need for Chest Tube Patency Standards, an area of focus at CVT Critical Care Conference

ClearFlow Participates in Clinical Panel Presentations and Round Table at Conference Focused on Clinical Impact of Retained Blood Washington, DC – October 6, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, participated in a series of panel presentations related to the subject of chest tube patency standards to prevent Retained Blood Syndrome (RBS) following cardiothoracic surgery last Friday at the Cardiovascular-Thoracic (CVT) Critical Care Conference in…

Read more